As the business world adopts a 24/7 timeframe, more companies are instituting controls that operate continuously. Talecris Biotherapeutics, a North Carolina-based maker of medical treatments, put in place a system that lets both business heads and the audit group keep tabs on controls.
The effort began as Talecris prepared to go public, a change that "meant that we needed to be able to focus everyone on controls," says Mary Ann Tourney, the company's senior director of internal audit. Given the audit department's size, automating testing of controls "would allow us time, with a small staff, to accomplish over 100 audit tests every week automatically, look at the results and engage the business process owners in looking at their own controls," Tourney says.
Talecris has two units: Talecris Biotherapeutics, which uses blood plasma to make treatments, and Talecris Plasma Resources, a chain of plasma collection centers.
Complete your profile to continue reading and get FREE access to Treasury & Risk, part of your ALM digital membership.
Your access to unlimited Treasury & Risk content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical Treasury & Risk information including in-depth analysis of treasury and finance best practices, case studies with corporate innovators, informative newsletters, educational webcasts and videos, and resources from industry leaders.
- Exclusive discounts on ALM and Treasury & Risk events.
- Access to other award-winning ALM websites including PropertyCasualty360.com and Law.com.
*May exclude premium content
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
